Manginsay, Art Ariz C.
HRN: 22-41-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/11/2023
10/18/2023
PO
3.5ml
Q8hours
Acute Gastroenteritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes